GlassScriptPhysician profile
Kimberly Wilson
NPI 1326420001
$8,663.07
in general payments reported to CMS, 2019-2025
20 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,754 · 2020: $592 · 2021: $2,310 · 2022: $3,564 · 2023: $30.04 · 2024: $140 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,227.03 | 2021-2022 | |
| Edwards Lifesciences Corporation | $2,447.42 | 2021-2025 | Sapien 3 Ultra Resilia |
| Medical Device Business Services, INC. | $860.38 | 2019 | |
| Abbott Laboratories | $344.62 | 2019-2025 | Coroflow, Optis |
| Biosense Webster, INC. | $289.89 | 2019-2020 | |
| Pfizer INC. | $252.52 | 2019-2020 | |
| Medtronic Vascular, INC. | $202.50 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $149.83 | 2019-2020 | |
| Penumbra, INC. | $144.01 | 2019 | |
| Cardiovascular Systems INC. | $136.16 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $115.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $95.61 | 2019-2020 | |
| Shockwave Medical, INC | $79.11 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.76 | 2019-2020 | |
| Medline Industries LP | $71.28 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $57.96 | 2019-2020 | |
| Abiomed | $42.97 | 2022 | |
| Boston Scientific Corporation | $25.90 | 2019 | |
| Cardiva Medical, INC. | $24.24 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.